Your browser doesn't support javascript.
loading
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study.
Arango, Celso; Bobes, Julio; Kirkpatrick, Brian; Garcia-Garcia, Margarida; Rejas, Javier.
Affiliation
  • Arango C; Psychiatry Department, Hospital General Universitario Gregorio Marañón and Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain. carango@hggm.es
Eur Neuropsychopharmacol ; 21(12): 867-75, 2011 Dec.
Article in En | MEDLINE | ID: mdl-21477998

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents / Coronary Disease / Metabolic Syndrome Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2011 Document type: Article Affiliation country: Spain Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents / Coronary Disease / Metabolic Syndrome Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2011 Document type: Article Affiliation country: Spain Country of publication: Netherlands